The Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025 (SCREENS for Cancer Act) reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal years 2026 through 2030 and makes targeted improvements to broaden access and improve outcomes. It updates program authorities to include navigation, evidence-based strategies, and access enhancements designed to increase screening and reduce disparities among low-income, uninsured, or underinsured women.
The bill also provides new or extended funding levels and establishes a Government Accountability Office (GAO) study to assess the program’s reach, trends, and barriers to access. Together, these changes aim to reach more women earlier in the cancer journey and ensure appropriate follow-up services.
In short, SCREENS for Cancer Act strengthens, funds, and modernizes NBCCEDP with a focus on equity, navigation, and accountable oversight. It does not create new screening technologies per se, but it broadens the program’s scope and capacity to get eligible women screened and into timely diagnostic pathways, while tracking progress and barriers through a formal GAO study.
At a Glance
What It Does
The bill reauthorizes NBCCEDP through 2030 and expands authorized activities to include navigation of health care services, implementation of evidence-based strategies proven to raise screening rates, and facilitated access to screening and diagnostic services. It also updates certain programmatic language to emphasize prevention alongside detection and control, and it adjusts reporting and oversight.
Who It Affects
Directly affects NBCCEDP participants—primarily low-income, uninsured, or underinsured women across states, the District of Columbia, territories, and tribal communities—along with the clinics and public health agencies that administer NBCCEDP.
Why It Matters
Expands access to screening, reduces geographic and cultural disparities, and strengthens program management and accountability through enhanced navigation, evidence-based practices, and a formal, auditable funding stream.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The NBCCEDP has existed since 1990 to provide screening and diagnostic services to underserved women. The SCREENS for Cancer Act of 2025 reauthorizes NBCCEDP for FY 2026–FY 2030 and makes several substantive improvements.
It authorizes $235 million per year for NBCCEDP during this period, reflecting a sustained federal commitment to expanding early detection. The bill requires NBCCEDP to incorporate patient navigation and other strategies that help patients move from screening to diagnosis and treatment when needed, and to adopt evidence-based approaches shown to boost screening in real-world health care settings.
The act also revises the program’s statutory language to place stronger emphasis on prevention, in addition to detection and control of cancer, and to ensure that “appropriate follow-up services” are provided rather than relying on traditional language about case management. It updates oversight and reporting provisions, including changing the reference to the authorizing agency to Health, Education, Labor, and Pensions, and extending the relevant reporting cadence.
Finally, the bill requires a GAO study not later than September 30, 2027, to estimate the number of eligible individuals, summarize trends in those served, and identify barriers to access—giving policymakers a clearer view of the program’s effectiveness and gaps.Taken together, SCREENS for Cancer Act aims to reach more women earlier, reduce disparities in cancer outcomes, and deliver measurable improvements in screening uptake and follow-up care while keeping a clear line of sight on program performance.
The Five Things You Need to Know
The bill authorizes NBCCEDP funding at $235 million per year for FY 2026–FY 2030.
The program will add patient navigation and evidence-based strategies to increase screening.
Program language is updated to emphasize prevention along with detection and control, including ensuring follow-up services.
A GAO study is required, with a report due by September 30, 2027, assessing eligibility, trends, and barriers.
The act expands NBCCEDP reach to geographic or cultural isolates, extending service to states, DC, territories, and tribal communities.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
Establishes the act’s common name as the SCREENS for Cancer Act of 2025 (Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025). The section sets the framework for subsequent amendments to the Public Health Service Act and clarifies the act’s scope.
Findings and NBCCEDP Enhancements
Sets out congressional findings on breast and cervical cancer incidence and mortality, the NBCCEDP’s history and reach, and its role in reducing disparities. It adds emphasis on outreach to geographically or culturally isolated populations and expands the program’s purposes to include enhanced navigation, access to screening, and implementation of evidence-based strategies proven to improve screening uptake in health care settings.
NBCCEDP Amendments and Funding
Amends Title XV of the Public Health Service Act to update programmatic language and authorize expanded activities, including follow-up support and prevention alongside detection and control. It restructures certain subsections to emphasize ensuring access to screening and diagnostics, updates the reporting relationship (to Health, Education, Labor, and Pensions), and authorizes $235 million per year for FY 2026–FY 2030 for NBCCEDP, with related adjustments to funding history and reporting requirements.
GAO Study
Requires the Comptroller General to report to the Senate and House committees by September 30, 2027 on NBCCEDP’s work, including eligible population estimates, trends in individuals served, and barriers to access. This section lays groundwork for ongoing evaluation of program reach and effectiveness.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Low-income, uninsured, or underinsured women across all states, DC, territories, and tribal communities gain greater access to screening and faster follow-up when indicated.
Who Bears the Cost
- Federal NBCCEDP funding increases; budgetary implications for annual appropriations.
Key Issues
The Core Tension
The central tension is between expanding NBCCEDP to reach more underserved populations with navigation and prevention-focused enhancements, and the finite federal budget available to sustain a five-year program with higher per-year funding and new administrative requirements. Balancing reach and impact with cost and operational feasibility will determine how effectively the added provisions translate into earlier detection and improved outcomes.
The bill’s expansion brings important benefits but also implementation challenges. Expanded navigation and evidence-based strategies require additional staff, training, and data infrastructure in clinics and public health departments.
Realizing the goal of equitable access will depend on the capacity of local providers to absorb new workflows and on the availability of follow-up services and diagnostic resources in underserved communities. The GAO study will generate data to inform future funding and program design, but it may take time for outcomes to materialize.
Privacy, data sharing, and the accuracy of eligibility determinations will be practical considerations as the program scales.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.